We are live on
!
Find out more
OQS
Occudo Quantitative Strategies Portfolio holdings
AUM
$1.84B
1-Year Est. Return
22.15%
This Fund
S&P 500
This Quarter
Est. Return
+8.53%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
–
AUM
$1.1B
AUM Growth
+$245M
(+29%)
Cap. Flow
+$234M
Cap. Flow
% of AUM
21.19%
Top 10 Holdings %
Top 10 Hldgs %
8.02%
Holding
1,300
New
383
Increased
225
Reduced
257
Closed
427
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$9.28M |
| 2 |
CSX Corp
CSX
|
+$9.14M |
| 3 |
Emerson Electric
EMR
|
+$8.99M |
| 4 |
Xcel Energy
XEL
|
+$8.88M |
| 5 |
Exelon
EXC
|
+$8.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$3.66M |
| 2 |
The Mosaic Company
MOS
|
+$3.64M |
| 3 |
Ulta Beauty
ULTA
|
+$3.63M |
| 4 |
Marvell Technology
MRVL
|
+$3.63M |
| 5 |
Hasbro
HAS
|
+$3.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.05% |
| 2 | Consumer Discretionary | 18.16% |
| 3 | Industrials | 16.37% |
| 4 | Consumer Staples | 8.29% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Cue Biopharma
CUE
$112M
| $46.9K | ﹤0.01% |
438
-51
| -10% | -$4.86K |
|
|
GAN
852
DELISTED
GAN Ltd
GAN
| $42.3K | ﹤0.01% |
32,764
+6,829
| +26% | +$12.4K |
|
853
Milestone Pharmaceuticals
MIST
$146M
| $41.2K | ﹤0.01% |
10,460
-28,668
| -73% | -$105K |
|
854
Precision BioSciences
DTIL
$188M
| $40.6K | ﹤0.01% |
1,794
-488
| -21% | -$16.1K |
|
|
ADVM
855
DELISTED
Adverum Biotechnologies
ADVM
| $37.7K | ﹤0.01% |
5,256
-2,578
| -33% | -$18.2K |
|
|
PHLT
856
DELISTED
Performant Healthcare Inc
PHLT
| $34.7K | ﹤0.01% |
+10,199
| New | +$33.4K |
|
857
Smith Micro Software
SMSI
$15.7M
| $34.1K | ﹤0.01% |
+735
| New | +$65.9K |
|
858
Barnes & Noble Education
BNED
$447M
| $33.6K | ﹤0.01% |
221
-36
| -14% | -$7.25K |
|
859
Praxis Precision Medicines
PRAX
$8.64B
| $33.4K | ﹤0.01% |
2,751
-163
| -6% | -$6.88K |
|
860
American Well
AMWL
$174M
| $32.3K | ﹤0.01% |
685
-18
| -3% | -$1.15K |
|
861
Quantum Corp
QMCO
$451M
| $31.4K | ﹤0.01% |
1,364
| – | – |
|
862
Absci
ABSI
$1.44B
| $29.3K | ﹤0.01% |
+16,717
| New | +$40.5K |
|
863
Aemetis
AMTX
$114M
| $29.1K | ﹤0.01% |
12,535
+2,040
| +19% | +$7.6K |
|
864
Passage Bio
PASG
$14.9M
| $26.6K | ﹤0.01% |
1,388
| – | – |
|
|
ATYR
865
aTyr Pharma
ATYR
$51.9M
| $25K | ﹤0.01% |
+11,922
| New | +$26.1K |
|
866
Ginkgo Bioworks
DNA
$612M
| $24.5K | ﹤0.01% |
+460
| New | +$29.1K |
|
867
American Resources Corp
AREC
$217M
| $23.9K | ﹤0.01% |
15,953
-72,423
| -82% | -$108K |
|
|
JOAN
868
DELISTED
JOANN, Inc. Common Stock
JOAN
| $22.2K | ﹤0.01% |
+13,991
| New | +$45K |
|
869
Inseego
INSG
$126M
| $21.4K | ﹤0.01% |
3,677
| – | – |
|
870
Vroom Inc
VRM
$36.7M
| $13.1K | ﹤0.01% |
183
-2,657
| -94% | -$215K |
|
|
CYXT
871
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
| $12.4K | ﹤0.01% |
40,754
-72,876
| -64% | -$154K |
|
872
Bioventus
BVS
$909M
| $11.5K | ﹤0.01% |
10,739
-39,022
| -78% | -$74.6K |
|
873
Instil Bio
TIL
$49.2M
| $10.3K | ﹤0.01% |
780
-91
| -10% | -$1.34K |
|
874
Applied Optoelectronics
AAOI
$10.6B
| – | – |
-15,249
| Closed | -$28.8K |
|
875
Accel Entertainment
ACEL
$990M
| – | – |
-35,430
| Closed | -$273K |
|
Similar funds
RP
ABTD
KAM
FCIM
CPSAC
OFS
LOAME
DP
Occudo Quantitative Strategies's Q1 2023 Portfolio in Review
As of Q1 2023, Occudo Quantitative Strategies held 1,300 positions worth $1.1B, up 29% from $859M the previous quarter. Its ten largest holdings account for 8% of the portfolio.
Occudo Quantitative Strategies deployed $234M of net new capital in Q1 2023, opening 383 new positions and adding to 225 existing holdings. Its largest new stake was Sherwin-Williams: 40,550 shares worth $9.11M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Ferrari, an estimated $3.66M trimmed.
- Occudo Quantitative Strategies's largest Q1 2023 buy was Sherwin-Williams: 40,550 shares worth $9.11M.
- Occudo Quantitative Strategies added most to Brown-Forman Class B in Q1 2023, an estimated $7.93M increase.
- Occudo Quantitative Strategies's biggest Q1 2023 reduction was Ferrari, cutting an estimated $3.66M.
- Occudo Quantitative Strategies fully exited The Mosaic Company in Q1 2023, selling an estimated $3.64M.
- Occudo Quantitative Strategies's ten largest holdings make up 8% of its $1.1B portfolio in Q1 2023.
- Occudo Quantitative Strategies opened 383 new positions and closed 427 in Q1 2023.
- Occudo Quantitative Strategies's portfolio value rose 29% quarter-over-quarter to $1.1B.
Based on Occudo Quantitative Strategies's 13F filing for Q1 2023, filed 15 May 2023.